Inhibitory effect of adeno-associated virus-mediated gene transfer of human endostatin on hepatocellular carcinoma

World Journal of Gastroenterology

Volumn 11, Issue 22, 2005, Pages 3331-3334

  Liu, Hong ^a   Peng, Cheng Hong ^b   Liu, Ying Bin ^a   Wu, Yu Lian ^a   Zhao, Zhi Ming ^a   Wang, Yong ^a   Han, Bao San ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Adeno associated virus; Endostatin; Gene; Hepatocellular carcinoma

Indexed keywords

ANGIOGENESIS INHIBITOR; ENDOSTATIN; PARVOVIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TUMOR VOLUME; VIRAL GENE DELIVERY SYSTEM;

EID: 21044453333     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i22.3331     Document Type: Article

References (29)

1. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88: 277-285
2. Boehm T, Folkman J, Browder T, O'Reilly MS. Antiangoiogentic therapy of experimental cancer dose not induce acquired drug resistance. Nature 1997; 390: 404-407
3. Dhanabal M, Ramchandran R, Volk R, Stillman IE, Lombardo M, Iruela-Arispe ML, Simon M, Sukhatme VP. Endostatin: yeast production, mutants,and antitumor effect in renal cell carcinoma. Cancer Res 1999; 59: 189-197
4. Ackley BD, Crew JR, Elamaa H, Pihlajaniemi T, Kuo CJ, Kramer JM. The NC1/endostatin domein of Caenorhabditis elegans type XVIII collagen affects cell migration and axon guidance. J Cell Biol 2001; 152: 1219-1232
5. Dhanabal M, Ramchandran R, Waterman MJ, Lu H, Knevelmann B, Segal M, Sukhatme VP. Endostatin induces endothelial cell apoptosis. J Biol Chem 1999; 274: 11721-11726
6. Yoon SS, Eto H, Lin CM, Nakamura H, Pawlik TM, Song SU, Tanabe KK. Mouse endostatin inhibits the formation of lung and liver metastases. Cancer Res 1999; 59: 6251-6256
7. Perletti G, Concari P, Giardini R, Marras E, Piccinini F, Folkman J, Chen L. Antitumor activity of endostatin against carcinogen-induced rat primary mammary tumors. Cancer Res 2000; 60: 1793-1796
8. Yokoyama Y, Green JE, Sukhatme VP, Ramakrishnan S. Effect of endostatin on spontaneous tumorigenesis of mammary adenocarcinomas inatransgenic mouse model. Cancer Res 2000; 60: 4362-4365
9. Shi W, Teschendorf C, Muzyczka N, Siemann DW. Adeno-associated virus-mediated gene transfer of endostatin inhibits angiogenesis and tumor growth in vivo. Cancer Gene Ther 2002; 9: 513-521
10. Musso O, Theret N, Heljasvaara R, Rehn M, Turlin B, Campion JP, Pihlajaniemi T, Clement B. Tumor hepatocytes and basement membrane- producing cells specifically express two different forms of the endostatin precursor,collagen X VIII in human liver cancers. Hepatology 2001; 33: 868-876
11. Musso O, Rehn M, Theret N, Turlin B, Bioulac-Sage P, Lotrian D, Campion JP, Pihlajaniemi T, Clement B. Tumor progression is associated with a significant decrease in the expression of the endostatin precursor collagen XVIII in human hepatocellular carcinomas. Cancer Res 2001; 61: 45-49
12. Dhar DK, Ono T, Yamanoi A, Soda Y, Yamaguchi E, Rahman MA, Kohno H, Nagasue N. Serum endostatin predicts tumor vascularity in hepatocellular carcinoma. Cancer 2002; 95: 2188-2195
13. Solaun MS, Mendoza L, De Luca M, Gutierrez V, Lopez MP, Olaso E, Lee Sim BK, Vidal-Vanaclocha F. Endostatin inhibits murine colon carcinoma sinusoidal-type metastases by preferential targeting of hepatic sinusoidal endothelium. Hepatology 2002; 35: 1104-1116
14. Miyashita M, Tajiri T, Yanagi K, Shimizu T, Futami R, Sasajima K, Tokunaga A. Serum levels of vascular endothelial growth factor, basic fibroblast growth factor and endostatin in human metastatic liver tumors. Hepatogastroenterology 2003; 50: 308-309
15. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic during tumorigenesis. Cell 1996; 86: 353-364
16. Hahnfeldt P, Panigraphy D, Folkman J, Hlatky L. Tumor development under angiogenic signaling: a dynamical theory of tumor growth,treatment response and postvascular dormancy. Cancer Res 1999; 59: 4770-4775
17. Wu J, Fan DM. Angiogenesis and antiangiogenesis therpy. Shijie Huaren Xiaohua Zazhi 2001; 9: 316-321
18. Abdollahi A, Lipson KE, Sckell A, Zieher H, Klenke F, Poerschke D, Roth A, Han X, Krix M, Bischof M, Hahnfeldt P, Grone HJ, Debus J, Hlatky L, Huber PE. Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects. Cancer Res 2003; 63: 8890-8898
19. Chillemi F, Francescato P, Ragg E, Cattaneo MG, Pola S, Vicentini L. Studies on the structure-activity relationship of endostatin: synthesis of human endostatin peptides exhibiting potent antiangiogenic activities. J Med Chem 2003; 46: 4165-4172
20. Li Z, Pan X, Pan W, Cao GS, Wen ZZ, Fang GE, Qi ZT, Bi JW, Hua JD. Packaging and identification of recombinant adenovirus carrying endostatin soluble vascular endothelial growth inhibitor gene. Shijie Huaren Xiaohua Zazhi 2003; 11: 741-744
21. Nguyen JT, Wu P, Clouse ME, Hlatky L, Terwilliger EF. Adeno-associated virus-mediated delivery of antiangiogenic factors as an antitumor strategy. Cancer Res 1998; 58: 5673-5677
22. Lu Y. Recombinant adeno-associated virus as delivery vector for gene therapy. Stem Cells Dev 2004; 13: 133-145
23. During MJ, Xu R, Young D, Kaplitt MG, Sherwin RS, leone P. Peroral gene therapy of lactose intolerance using an adeno-associated virus vector. Nat Med 1998; 4: 1131-1135
24. Ponnazhagan S, Mukherjee P, Yoder MC,Wang XS, Zhou SZ, Kaplan J, Wadsworth S, Srivastava A. Aden-associated virus 2-mediated gene transter in vivo: organ-tropism and expression of transduced sepuences in mice. Gene 1997; 190: 203-210
25. Wu ZJ, Wu XB, Cao H, Dong XY, Wang H, Hou YD. A novel and highly efficient production system for recombinant adeno-associated virus vector. Science in China 2001; 31: 423-430
26. Bergers G, Javaherian K, Lo KM, Folkman J, Hanahan D. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 1999; 284: 808-812
27. Hanna NN, Seetharam S, Mauceri HJ, Beckett MA, Jaskowiak NT, Salloum RM, Hari D, Dhanabal M, Ramchandran R, Kalluri R, Sukhatme VP, Kufe DW, Weichselbaum RR. Antitumor interaction of short-course endostatin and ionizing radiation. Cancer J 2000; 6: 287-293
28. Shi W, Teschendorf C, Muzyczka N, Siemann DW. Gene therapy delivery of endostatin enhances the treatment efficacy of radiation. Radiother Oncol 2003; 66: 1-9
29. Plum SM, Hanson AD, Volker KM, Vu HA, Sim BKL, Fogler WE, Fortier AH. Synergistic activity of recombinant human endostatin in combination with adriamycin: analysis of in vitro activity on endothelial cells and in vivo tumor progression in an orthotopic murine mammary carcinoma model. Clin Cancer Res 2003; 9: 4619-4626